1. Home
  2. XPRO vs AVDL Comparison

XPRO vs AVDL Comparison

Compare XPRO & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XPRO
  • AVDL
  • Stock Information
  • Founded
  • XPRO 1938
  • AVDL 2015
  • Country
  • XPRO United States
  • AVDL Ireland
  • Employees
  • XPRO N/A
  • AVDL N/A
  • Industry
  • XPRO Oilfield Services/Equipment
  • AVDL Biotechnology: Pharmaceutical Preparations
  • Sector
  • XPRO Energy
  • AVDL Health Care
  • Exchange
  • XPRO Nasdaq
  • AVDL Nasdaq
  • Market Cap
  • XPRO 935.2M
  • AVDL 784.6M
  • IPO Year
  • XPRO 2013
  • AVDL 1996
  • Fundamental
  • Price
  • XPRO $8.32
  • AVDL $9.11
  • Analyst Decision
  • XPRO Buy
  • AVDL Strong Buy
  • Analyst Count
  • XPRO 3
  • AVDL 6
  • Target Price
  • XPRO $12.00
  • AVDL $18.17
  • AVG Volume (30 Days)
  • XPRO 1.1M
  • AVDL 1.3M
  • Earning Date
  • XPRO 07-24-2025
  • AVDL 05-07-2025
  • Dividend Yield
  • XPRO N/A
  • AVDL N/A
  • EPS Growth
  • XPRO N/A
  • AVDL N/A
  • EPS
  • XPRO 0.58
  • AVDL N/A
  • Revenue
  • XPRO $1,720,185,000.00
  • AVDL $194,450,000.00
  • Revenue This Year
  • XPRO N/A
  • AVDL $55.11
  • Revenue Next Year
  • XPRO $2.76
  • AVDL $30.13
  • P/E Ratio
  • XPRO $14.30
  • AVDL N/A
  • Revenue Growth
  • XPRO 10.48
  • AVDL 252.64
  • 52 Week Low
  • XPRO $6.70
  • AVDL $6.38
  • 52 Week High
  • XPRO $24.50
  • AVDL $17.30
  • Technical
  • Relative Strength Index (RSI)
  • XPRO 49.29
  • AVDL 53.96
  • Support Level
  • XPRO $7.57
  • AVDL $8.77
  • Resistance Level
  • XPRO $8.70
  • AVDL $9.31
  • Average True Range (ATR)
  • XPRO 0.33
  • AVDL 0.41
  • MACD
  • XPRO 0.07
  • AVDL -0.04
  • Stochastic Oscillator
  • XPRO 46.87
  • AVDL 53.60

About XPRO Expro Group Holdings N.V.

Expro Group Holdings NV offers products and services that span the well life cycle, including well construction, well flow management, well intervention and integrity, and subsea well access. It maintains operations around the world and specializes in offshore production solutions. It also provides production optimization for both onshore and offshore applications. The company has four operating segments: North and Latin America (NLA); Europe and Sub-Saharan Africa (ESSA); Middle East and North Africa (MENA), and Asia-Pacific (APAC). The majority of its revenue is derived from North and Latin America (NLA) segment.

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

Share on Social Networks: